➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Last Updated: April 20, 2021

DrugPatentWatch Database Preview

Insulin human - Biologic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for insulin human

Identify potential brand extensions & biosimilar entrants

Gansu Provincial People's HospitalEarly Phase 1
Fengmei LianEarly Phase 1
Affiliated Hospital of Changchun University of Chinese MedicineEarly Phase 1

See all insulin human clinical trials

Recent Litigation for insulin human

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Par Pharmaceutical, Inc. v. Amneal Pharmaceuticals of New York, LLC2018-12-19
Par Pharmaceutical, Inc. v. Eagle Pharmaceuticals, Inc.2018-05-31

See all insulin human litigation

Patent Text Search: US Patents for insulin human

These patents were identified by searching patent claims

Supplementary Protection Certificates for insulin human

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2017 00020 Denmark   Start Trial PRODUCT NAME: INSULIN GLARGINE/LIXISENATID; REG. NO/DATE: EU/1/16/1157/001-004 20170113
2013000061 Germany   Start Trial PRODUCT NAME: INSULIN DEGLUDEC IN ALLEN DURCH DAS BASISPATENT GESCHUETZTEN FORMEN; REGISTRATION NO/DATE: EU/1/12/807/001 EU/1/12/807/004-005 EU/1/12/807/007-009 EU/1/12/807/012-013 EU/1/12/807/015 20130121
04/015 Ireland   Start Trial PRODUCT NAME: INSULIN DETEMIR; NAT REGISTRATION NO/DATE: EU/1/04/278/001-009 20040601; FIRST REGISTRATION NO/DATE: CH 56370 56371 56372 20031110; PAEDIATRIC INVESTIGATION PLAN: P/0172/2014
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.